Biofilm Formation by Pathogens Causing Ventilator-Associated Pneumonia at Intensive Care Units in a Tertiary Care Hospital: An Armor for Refuge

Table 7

Relation between drug resistance and biofilm production in Acinetobacter calcoaceticus baumannii complex.

Antibiotics	Biofilm				value
	Producer		Nonproducer
	Sensitive	Resistant	Sensitive	Resistant
Amikacin	1 (14.3%)	6 (85.7%)	1 (20.0%)	4 (80.0%)	0.793
Levofloxacin	1 (14.3%)	6 (85.7%)	2 (40.0%)	3 (60.0%)	0.310
Ceftazidime	0	7 (100.0%)	0	5(100.0%)
Cefepime	0	7 (100.0%)	0	5(100.0%)
Piperacillin/tazobactam	1 (14.3%)	6 (85.7%)	2 (40.0%)	3 (60.0%)	0.310
Cefoperazone/sulbactam	2 (28.6%)	5 (71.4%)	2 (40.0%)	3 (60.0%)	0.679
Ampicillin/sulbactam	2 (28.6%)	5 (71.4%)	2 (40.0%)	3 (60.0%)	0.679
Meropenem	1 (14.3%)	6 (85.7%)	1 (20.0%)	4 (80.0%)	0.793
Imipenem	1 (14.3%)	6 (85.7%)	1 (20.0%)	4 (80.0%)	0.793
Colistin	7 (100.0%)	0	5(100.0%)	0
Doxycycline	0	7 (100.0%)	0	5(100.0%)